Current Tobacco Use Declining in U.S. Youth in 2024
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Oct. 18, 2024 -- Tobacco use among U.S. youth continued to decline in 2024, according to a study published in the Oct. 17 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Ahmed Jamal, M.B.B.S., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues analyzed data from the 2024 National Youth Tobacco Survey to determine tobacco product use among U.S. middle school (grades 6 to 8) and high school (grades 9 to 12) students.
The researchers found that in 2024, current (previous 30-day) use of any tobacco product was reported by 10.1 percent of high school students (representing 1.58 million students) and 5.4 percent of middle school students (representing 640,000 students). The most commonly reported tobacco products currently used were electronic cigarettes (5.9 percent), overall, followed by nicotine pouches (1.8 percent), cigarettes (1.4 percent), cigars (1.2 percent), smokeless tobacco (1.2 percent), other oral nicotine products (1.2 percent), heated tobacco products (0.8 percent), hookahs (0.7 percent), and pipe tobacco (0.5 percent). From 2023 to 2024, the estimated number of students who reported current use of any tobacco product decreased from 2.80 to 2.25 million students, while e-cigarette use decreased from 2.13 to 1.63 million students, which was driven by decreases in high school students.
“Tobacco use among youths has continued to decline; however, comprehensive and sustained implementation of evidence-based tobacco control strategies, including tobacco product regulation and enforcement, is needed to prevent and reduce all forms of youth tobacco product use,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-19 12:00
Read more
- Ultra-processed Foods May Raise Colon Cancer Risk
- Frito-Lay Recalls Lay's Chips Due to Milk Allergy Concerns
- Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
- Wintertime Is Prime Time for Head Lice: What Parents Need to Know
- FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis
- Study Supports HPV Self-Testing for Cervical Cancer Screening
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions